Long-term outcome in Japanese patients with lupus nephritis

Lupus

Volumn 23, Issue 11, 2014, Pages 1124-1132

  Kono, M ^a   Yasuda, S ^a   Kato, M ^a   Kanetsuka, Y ^a   Kurita, T ^a   Fujieda, Y ^a   Otomo, K ^a   Horita, T ^a   Oba, K ^b   Kondo, M ^c   Mukai, M ^c   Yanai, M ^c   Fukasawa, Y ^c   Atsumi, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

Nephritis; Renal lupus; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; END STAGE RENAL DISEASE; FEMALE; HUMAN; JAPANESE (PEOPLE); LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; SURVIVAL TIME; AGED; JAPAN; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84928150388     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314536246     Document Type: Article

References (53)

1. McCluskey RT, Lupus nephritis. In: Sommers SC (ed.), Kidney pathology decennial. East Norwalk, CT: Appleton-Century-Crofts, 1975. pp. 435-450.
2. Churg J, Sobin LH. Renal disease: Classification and atlas of glomerular diseases. Tokyo, New York: Igaku-Shoin, 1982. pp. 127-131.
3. Churg J, Bernstein, Glassock RJ. Classification and atlas of glomerular diseases, 2nd ed. Tokyo, NewYork: Igaku-Shoin, 1995. pp. 151-156.
4. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530.
5. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999; 10: 413-424.
6. Houssiau FA, Ginzler EM. Current treatment of lupus nephritis. Lupus 2008; 17: 426-430.
7. Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN. Review: Lupus nephritis: Pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 2010; 19: 557-574.
8. Houssiau FA, Vasconcelos C, D'Cruz D, et al. The 10-year followup data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 2010; 69: 61-64.
9. Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology 2006; 45: 1144-1147.
10. Alarcón GS, McGwin Jr G, Petri M, Reveille JD, Ramsey- Goldman R, Kimberly RP. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95-101.
11. Austin 3rd HA, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995; 10: 1620-1628.
12. Barr RG, Seliger S, Appel GB, et al. Prognosis in proliferative lupus nephritis: The role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 2003; 18: 2039-2046.
13. Bastian HM, Roseman JM, McGwin Jr G, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 152-160.
14. Contreras G, Lenz O, Pardo V, et al. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 2006; 69: 1846-1851.
15. Korbet SM, Schwartz MM, Evans J, Lewis EJ. Severe lupus nephritis: Racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244-254.
16. Seligman VA, Lum RF, Olson JL, Li H, Criswell LA. Demographic differences in the development of lupus nephritis: A retrospective analysis. Am J Med 2002; 112: 726-729.
17. Faurschou M, Dreyer L, Kamper AL, Starklint H, Jacobsen S. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res 2010; 62: 873-880.
18. Mok CC, Kwok RC, Yip PS. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum 2013; 65: 2154-2160.
19. Yap DY, Tang CS, Ma MK, Lam MF, Chan TM. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant 2012; 27: 3248-3254.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
21. Gladman DD, Ibañez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002; 29: 288-291.
22. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association- European Dialysis and Transplant Association (EULAR/ERAEDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012; 71: 1771-1782.
23. Austin 3rd HA, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983; 75: 382-391.
24. Funauchi M, Shimadzu H, Tamaki C, et al. Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: Results from a single center. Rheumatol Int 2007; 27: 243-249.
25. Al Durahim H, Al Ghamdi G, Al Seraya A, Al khiari R, Al Sayyari A. Predictors of mortality and end stage renal disease in Saudi patients with lupus nephritis. Lupus 2011; 20: 1329-1335.
26. Lin WH, Guo CY, Wang WM, et al. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: A nationwide cohort study in Taiwan. Int J Rheum Dis 2013; 16: 747-753.
27. Mok MY, Li WL. Do Asian patients have worse lupus? Lupus 2010; 19: 1384-1390.
28. Al Arfaj AS, Khalil N. Al Saleh S. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia. Rheumatol Int 2009; 29: 1057-1067.
29. Sisó A, Ramos-Casals M, Bové A, et al. Outcomes in biopsyproven lupus nephritis: Evaluation of 190 white patients from a single center. Medicine (Baltimore) 2010; 89: 300-307.
30. Ishikawa S, Kayaba K, Gotoh T, et al. Incidence of total stroke, stroke subtypes, and myocardial infarction in the Japanese population: The JMS Cohort Study. J Epidemiol 2008; 18: 144-150.
31. Moon SJ, Kwok SK, Ju JH, et al. Predictors of chronic kidney disease in Korean patients with lupus nephritis. J Rheumatol 2011; 38: 2588-2597.
32. Kojo S, Sada KE, Kobayashi M, et al. Clinical usefulness of a prognostic score in histological analysis of renal biopsy in patients with lupus nephritis. J Rheumatol 2009; 36: 2218-2223.
33. Hiramatsu N, Kuroiwa T, Ikeuchi H, et al. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology 2008; 47: 702-707.
34. Garcia MA, Marcos JC, Marcos AI, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 2005; 14: 938-946.
35. Soto ME, Vallejo M, Guillén F, Simón JA, Arena E, Reyes PA. Gender impact in systemic lupus erythematosus. Clin Exp Rheumatol 2004; 22: 713-721.
36. Andrade RM, Alarcón GS, Fernández M, Apte M, Vilá LM, Reveille JD. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum 2007; 56: 622-630.
37. Jacobsen S, Petersen J, Ullman S, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998; 17: 468-477.
38. Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol 2012; 39: 759-769.
39. Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology 2013; 52: 2108-2115.
40. Hsu CY, Chiu WC, Yang TS, et al. Age- And gender-related longterm renal outcome in patients with lupus nephritis. Lupus 2011; 20: 1135-1141.
41. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007; 6: 366-372.
42. Lockshin MD. Biology of the sex and age distribution of systemic lupus erythematosus. Arthritis Rheum 2007; 57: 608-611.
43. Lahita RG. Gender disparity in systemic lupus erythematosus, thoughts after the 8th International Congress on Systemic Lupus Erythematosus, Shanghai, China, 2007. J Clin Rheumatol 2008; 14: 185-187.
44. Petri M. Sex hormones and systemic lupus erythematosus. Lupus 2008; 17: 412-415.
45. Soares PM, Borba EF, Bonfa E, Hallak J, Corrêa AL, Silva CA. Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum 2007; 56: 2352-2361.
46. Smith-Bouvier DL, Divekar AA, Sasidhar M, et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008; 205: 1099-1108.
47. Chagnon P, Schneider R, Hebert J, et al. Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum 2006; 54: 1270-1278.
48. Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J Immunol 2006; 177: 2088-2096.
49. Carrel L. Molecular biology. "X"-rated chromosomal rendezvous. Science 2006; 311: 1107-1109.
50. Migeon BR. The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases. JAMA 2006; 295: 1428-1433.
51. Massardo L, Metz C, Pardo E, et al. Autoantibodies against galectin- 8: Their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Lupus 2009; 18: 539-546.
52. Oleinick A. Family studies in systemic lupus erythematosus. I. Prenatal factors. Arthritis Rheum 1969; 12: 10-16.
53. Wallace DJ. A reason for the rarity of male lupus. Lupus 1998; 7: 60.